|
|
|
|
| LEADER |
01573nam a2200277 u 4500 |
| 001 |
EB001874861 |
| 003 |
EBX01000000000000001038228 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
191026 r ||| eng |
| 245 |
0 |
0 |
|a Guide to the methods of technology appraisal 2013
|h Elektronische Ressource
|c National Institute for Health and Care Excellence
|
| 260 |
|
|
|a London
|b National Institute for Health and Care Excellence
|c 4 April 2013, 2013
|
| 300 |
|
|
|a 1 PDF file (94 pages)
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Technology Assessment, Biomedical / methods
|
| 653 |
|
|
|a United Kingdom
|
| 653 |
|
|
|a Technology Assessment, Biomedical / standards
|
| 653 |
|
|
|a Practice Guidelines as Topic
|
| 710 |
2 |
|
|a National Institute for Health and Care Excellence (Great Britain)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Process and methods guides
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK395867
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 600
|
| 520 |
|
|
|a The aim of good practice guidance is to provide recommendations for good practice for people who are involved in governing, prescribing and commissioning medicines, and those involved in decision-making about medicines. The content of the good practice guidance is developed according to the best available evidence. The guidance aims to be thorough, effective and appropriate to the target audience, with an emphasis on the implications for national practice
|